Alternative management of central serous chorioretinopathy using intravitreal metoprolol (2022)
Gonçalves, Annelise Nicotti; Scott, Ingrid U.; Jorge, Rodrigo 
Source: International Journal of Retina and Vitreous. Unidade: FMRP
Subjects: OFTALMOPATIAS, DOENÇAS RETINIANAS, BETA-BLOQUEADORES, RETINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Annelise Nicotti e SCOTT, Ingrid U. e JORGE, Rodrigo. Alternative management of central serous chorioretinopathy using intravitreal metoprolol. International Journal of Retina and Vitreous, v. 8, n. 50, p. 1-7, 2022Tradução . . Disponível em: https://doi.org/10.1186/s40942-022-00400-5. Acesso em: 27 jan. 2026.APA
Gonçalves, A. N., Scott, I. U., & Jorge, R. (2022). Alternative management of central serous chorioretinopathy using intravitreal metoprolol. International Journal of Retina and Vitreous, 8( 50), 1-7. doi:10.1186/s40942-022-00400-5NLM
Gonçalves AN, Scott IU, Jorge R. Alternative management of central serous chorioretinopathy using intravitreal metoprolol [Internet]. International Journal of Retina and Vitreous. 2022 ; 8( 50): 1-7.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1186/s40942-022-00400-5Vancouver
Gonçalves AN, Scott IU, Jorge R. Alternative management of central serous chorioretinopathy using intravitreal metoprolol [Internet]. International Journal of Retina and Vitreous. 2022 ; 8( 50): 1-7.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1186/s40942-022-00400-5
